Global Intellectual Property Center

Tag Archives: Compulsory licensing

Why the Race to Treat Malaria is More Like a Marathon

Why the Race to Treat Malaria is More Like a Marathon

© Kraivuttinun / iStock

Like finding the cure for cancer, this race to develop an antidote to malaria is more like a marathon. Health professionals have exhausted nearly 30 years of research and development and invested hundreds of millions of dollars to not just eradicate, but merely slow down the spread of malaria.

The Threat to Public Health Worse Than Obamacare

The Threat to Public Health Worse Than Obamacare

Image: ©iStockphoto.com / bonnie jacobs

Obamacare is bad enough. With burdensome regulations that strangle hiring, hurt small businesses, and disrupt healthcare, what more can we stand? Well, as it turns out, bad policies from overseas are also threatening to undo our healthcare system in an equally nefarious fashion.

India at an IP Crossroads

India at an IP Crossroads

Image: ©iStockphoto.com / N Vasuki Rao

Once as shining example for economic opportunity, local policymakers and the judiciary have puzzlingly set India on a course that has left the innovative industries unsettled. Earlier this week, the GIPC joined Former U.S. Trade Representative Charlene Barshefsky, Information Technology & Innovation Foundation’s (ITIF) Senior Analyst Stephen Ezell, and Third Way’s Senior Fellow for Trade Ed Gerwin in an event to discuss the ramifications of India’s rapidly deteriorating intellectual property (IP) environment.

India – The Outlier on Intellectual Property

India – The Outlier on Intellectual Property

While India’s economic ascent has been nothing short of miraculous, it is imperative that India take into account the importance of ensuring adequate IP rights as they consider expanding their trade and investment relationships globally.

IP is a Necessary Prescription for Innovation

IP is a Necessary Prescription for Innovation

By Mark Elliot

This week, the Global Intellectual Property Center (GIPC) participated in the Biotechnology Industry Organization (BIO) annual international convention, which brought together thousands of participants representing biopharmaceutical companies and associations from over two dozen countries under one roof in Boston, Massachusetts. 


 

We took this opportunity to engage business leaders, international and U.S. government officials, and emerging startups on the importance of intellectual property rights to their industries and countries.